Though it hasn't even wrapped up clinical trials, the weight loss drug retatrutide already has a cult following.

The Huntsville Planning Commission voted to rezone 73.40 acres east of Greenbrier Road and north of Interstate 565 in ...

It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.

MEDI&GENE, a biopharmaceutical company developing therapeutics for metabolic diseases, announced today that it has entered into a Catalyze agreement with Eli Lilly and Company (Lilly) to advance ...